Perisilencing of periostin inhibits nicotine-mediated tumor cell growth and epithelial-mesenchymal transition in lung cancer cells

Molecular Medicine Reports

Volumn 7, Issue 3, 2013, Pages 875-880

  Wu, Shu Qiang ^a   Lv, Ya Er ^a   Lin, Bai Hua ^a   Luo, Li Min ^a   Lv, Shi Liang ^a   Bi, Ai Hong ^a   Jia, Yong Shi ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Chemoresistance; Epithelial mesenchymal transition; Lung cancer; Migration; Nicotine; Periostin; SiRNA

Indexed keywords

ANTIBIOTIC G 418; CISPLATIN; HEXAMETHONIUM; MESSENGER RNA; NICOTINE; PROPIDIUM IODIDE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SNAIL; ANTINEOPLASTIC AGENT; CELL ADHESION MOLECULE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; POSTN PROTEIN, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; NUCLEOTIDE SEQUENCE; PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; CELL MOTION; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; NON SMALL CELL LUNG CANCER; TOXICITY;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CISPLATIN; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; LUNG NEOPLASMS; NICOTINE; NICOTINIC ANTAGONISTS; RECEPTORS, NICOTINIC; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84873117794     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1267     Document Type: Article

References (24)

1. Takeshita S, Kikuno R, Tezuka K and Amann E: Osteoblast specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J 294:271-278, 1993. (Pubitemid 23251940)
2. Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY and Chang DD: Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha (V) beta (3) and alpha (V) beta (5) integrins and promotes cell motility. Cancer Res 62:5358-5364, 2002. (Pubitemid 35024613)
3. Hamilton DW: Functional role of periostin in development and wound repair: implications for connective tissue disease. J Cell Commun Signal 2:9-17, 2008.
4. Puppin C, Fabbro D, Dima M, Di Loreto C, Puxeddu E, Filetti S, Russo D and Damante G: High periostin expression correlates with aggressiveness in papillary thyroid carcinomas. J Endocrinol 197:401-408, 2008. (Pubitemid 351696253)
5. Zhang Y, Zhang G, Li J, Tao Q and Tang W: The expression analysis of periostin in human breast cancer. J Surg Res 160:102-106, 2010.
6. Li JS, Sun GW, Wei XY and Tang WH: Expression of periostin and its clinicopathological relevance in gastric cancer. World J Gastroenterol 13:5261-5266, 2007.
7. Siriwardena BS, Kudo Y, Ogawa I, Kitagawa M, Kitajima S, Hatano H, Tilakaratne WM, Miyauchi M and Takata T: Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br J Cancer 95:1396-1403, 2006. (Pubitemid 44760092)
8. Shao R, Bao S, Bai X, Blanchette C, Anderson RM, Dang T, Gishizky ML, Marks JR and Wang XF: Acquired expression of Periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol 24:3992-4003, 2004. (Pubitemid 38496176)
9. Yan W and Shao R: Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation. J Biol Chem 281:19700-19708, 2006.
10. Hecht SS: Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 3:461-469, 2002. (Pubitemid 34863666)
11. Dasgupta P, Rizwani W, Pillai S, Kinkade R, Kovacs M, Rastogi S, Banerjee S, Carless M, Kim E, Coppola D, et al: Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines. Int J Cancer 124:36-45, 2009.
12. Hong L, Sun H, Lv X, Yang D, Zhang J and Shi Y: Expression of periostin in the serum of NSCLC and its function on proliferation and migration of human lung adenocarcinoma cell line (A549) in vitro. Mol Biol Rep 37:2285-2293, 2010.
13. Sasaki H, Dai M, Auclair D, Fukai I, Kiriyama M, Yamakawa Y, Fujii Y and Chen LB: Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas. Cancer 92:843-848, 2001. (Pubitemid 32783071)
14. Sasaki H, Lo KM, Chen LB, Auclair D, Nakashima Y, Moriyama S, Fukai I, Tam C, Loda M and Fujii Y: Expression of Periostin, homologous with an insect cell adhesion molecule, as a prognostic marker in non-small cell lung cancers. Jpn J Cancer Res 92:869-873, 2001. (Pubitemid 32894097)
15. Ruan K, Bao S and Ouyang G: The multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci 66:2219-2230, 2009.
16. Cucina A, Dinicola S, Coluccia P, Proietti S, D'Anselmi F, Pasqualato A and Bizzarri M: Nicotine stimulates proliferation and inhibits apoptosis in colon cancer cell lines through activation of survival pathways. J Surg Res: Mar. 10, 2012 (Epub ahead of print).
17. Do NY and Lim SC: A low level of nicotine-induced chemoresistance in a KB cell line. Mol Med Report 1:55-60, 2008.
18. Chen RJ, Ho YS, Guo HR and Wang YJ: Long-term nicotine exposure-induced chemoresistance is mediated by activation of Stat3 and downregulation of ERK1/2 via nAChR and beta-adrenoceptors in human bladder cancer cells. Toxicol Sci 115:118-130, 2010.
19. Martinez-Garcia E, Irigoyen M, Gonzalez-Moreno O, Corrales L, Teijeira A, Salvo E and Rouzaut A: Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatment. Toxicol Sci 116:467-476, 2010.
20. Xu L and Deng X: Protein kinase Ciota promotes nicotine-induced migration and invasion of cancer cells via phosphorylation of micro-and m-calpains. J Biol Chem 281:4457-4466, 2006. (Pubitemid 43847877)
21. Cooke JP: Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor. Life Sci 80:2347-2351, 2007. (Pubitemid 46818276)
22. Kanda Y and Watanabe Y: Nicotine-induced vascular endothelial growth factor release via the EGFR-ERK pathway in rat vascular smooth muscle cells. Life Sci 80:1409-1414, 2007. (Pubitemid 46367068)
23. Huber MA, Kraut N and Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17:548-558, 2005. (Pubitemid 41267170)
24. Gotti C and Clementi F: Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 74:363-396, 2004. (Pubitemid 40092737)